DK1233960T3 - Polymorft salt af anti-migræne lægemiddel - Google Patents

Polymorft salt af anti-migræne lægemiddel

Info

Publication number
DK1233960T3
DK1233960T3 DK00954864T DK00954864T DK1233960T3 DK 1233960 T3 DK1233960 T3 DK 1233960T3 DK 00954864 T DK00954864 T DK 00954864T DK 00954864 T DK00954864 T DK 00954864T DK 1233960 T3 DK1233960 T3 DK 1233960T3
Authority
DK
Denmark
Prior art keywords
migraine drug
polymorphic salt
polymorphic
salt
migraine
Prior art date
Application number
DK00954864T
Other languages
English (en)
Inventor
Arthur Bentley
Simon Arnold Howard-Field
Ronald James Ogilvie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK1233960T3 publication Critical patent/DK1233960T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK00954864T 1999-09-28 2000-09-14 Polymorft salt af anti-migræne lægemiddel DK1233960T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9922963.5A GB9922963D0 (en) 1999-09-28 1999-09-28 Polymorphic salt
PCT/IB2000/001305 WO2001023377A2 (en) 1999-09-28 2000-09-14 Polymorphic salt

Publications (1)

Publication Number Publication Date
DK1233960T3 true DK1233960T3 (da) 2003-10-27

Family

ID=10861767

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00954864T DK1233960T3 (da) 1999-09-28 2000-09-14 Polymorft salt af anti-migræne lægemiddel

Country Status (50)

Country Link
US (1) US6369094B1 (da)
EP (1) EP1233960B1 (da)
JP (1) JP3795395B2 (da)
KR (1) KR100479897B1 (da)
CN (1) CN1155594C (da)
AP (1) AP2004A (da)
AR (1) AR025779A1 (da)
AT (1) ATE246185T1 (da)
AU (1) AU779580B2 (da)
BG (1) BG65161B1 (da)
BR (1) BR0014272A (da)
CA (1) CA2379572C (da)
CO (1) CO5180567A1 (da)
CR (1) CR6561A (da)
CU (1) CU23200A3 (da)
CZ (1) CZ2002971A3 (da)
DE (1) DE60004262T2 (da)
DK (1) DK1233960T3 (da)
DZ (1) DZ3254A1 (da)
EA (1) EA004510B1 (da)
EE (1) EE200200171A (da)
EG (1) EG24143A (da)
ES (1) ES2200911T3 (da)
GB (1) GB9922963D0 (da)
GE (1) GEP20043365B (da)
GT (1) GT200000159A (da)
HK (1) HK1048628B (da)
HR (1) HRP20020270B1 (da)
HU (1) HUP0202821A3 (da)
IL (1) IL147154A (da)
IS (1) IS2162B (da)
MA (1) MA26821A1 (da)
MX (1) MXPA02003311A (da)
MY (1) MY121170A (da)
NO (1) NO321936B1 (da)
NZ (1) NZ516093A (da)
OA (1) OA12024A (da)
PA (1) PA8498901A1 (da)
PE (1) PE20010662A1 (da)
PL (1) PL354960A1 (da)
PT (1) PT1233960E (da)
SI (1) SI1233960T1 (da)
SK (1) SK3982002A3 (da)
TN (1) TNSN00187A1 (da)
TR (1) TR200200804T2 (da)
TW (1) TWI265926B (da)
UA (1) UA72272C2 (da)
WO (1) WO2001023377A2 (da)
YU (1) YU2602A (da)
ZA (1) ZA200202406B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060025387A1 (en) * 1998-12-23 2006-02-02 Cytoscan Sciences Llc Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
GB0018968D0 (en) * 2000-08-02 2000-09-20 Pfizer Ltd Particulate composition
US7132549B2 (en) 2003-05-30 2006-11-07 Pfizer Inc. Process
GB0312478D0 (en) * 2003-05-30 2003-07-09 Pfizer Ltd Improved process
EP1819323B2 (en) * 2004-12-03 2023-03-22 Merck Sharp & Dohme Corp. Pharmaceutical composition containing an anti-nucleating agent
JP2009511629A (ja) * 2005-10-17 2009-03-19 ニューロセラピューティクス ファーマ， インコーポレイテッド 中枢神経系疾患の調節に有用な利尿薬様化合物類似体
KR100814109B1 (ko) * 2006-01-09 2008-03-14 한국생명공학연구원 로다닌 유도체, 이의 제조방법 및 이를 유효성분으로함유하는 약학적 조성물
TWI394753B (zh) 2006-03-17 2013-05-01 Otsuka Pharma Co Ltd 新穎替妥牟拉（ｔｅｔｏｍｉｌａｓｔ）晶體
WO2010116386A2 (en) * 2009-04-08 2010-10-14 Biophore India Pharmaceuticals Pvt. Ltd. Novel polymorph of eletriptan hydrobromide and process for the preparation thereof
AU2010313571B2 (en) 2009-10-26 2014-07-31 Merck Sharp & Dohme Llc Solid pharmaceutical compositions containing an integrase inhibitor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545644A (en) 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5559246A (en) 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5559129A (en) 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5607951A (en) 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5578612A (en) 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
RU2095360C1 (ru) * 1990-10-15 1997-11-10 Пфайзер Инк. Производные индола, их оптические изомеры и фармацевтически приемлемые соли
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5998462A (en) * 1996-12-16 1999-12-07 Allelix Biopharmaceuticals Inc. 5-alkyl indole compounds
PL337803A1 (en) * 1997-07-03 2000-09-11 Pfizer Pharmaceutic agents containing eletriptane hemisulphate and caffeine

Also Published As

Publication number Publication date
KR20020032627A (ko) 2002-05-03
IS2162B (is) 2006-11-15
EA004510B1 (ru) 2004-04-29
BG65161B1 (bg) 2007-04-30
CR6561A (es) 2005-04-04
DZ3254A1 (fr) 2001-04-05
NO321936B1 (no) 2006-07-24
EE200200171A (et) 2003-06-16
NO20021525L (no) 2002-03-26
DE60004262D1 (de) 2003-09-04
CZ2002971A3 (cs) 2003-04-16
HK1048628B (zh) 2004-10-21
EG24143A (en) 2008-08-06
SK3982002A3 (en) 2003-05-02
HRP20020270B1 (en) 2004-04-30
BG106240A (en) 2002-07-31
AP2002002457A0 (en) 2002-06-30
YU2602A (sh) 2004-11-25
EP1233960A2 (en) 2002-08-28
HRP20020270A2 (en) 2003-06-30
MY121170A (en) 2005-12-30
GEP20043365B (en) 2004-05-10
CO5180567A1 (es) 2002-07-30
HK1048628A1 (en) 2003-04-11
ATE246185T1 (de) 2003-08-15
CN1155594C (zh) 2004-06-30
HUP0202821A3 (en) 2003-12-29
MA26821A1 (fr) 2004-12-20
SI1233960T1 (en) 2003-12-31
IL147154A0 (en) 2002-08-14
IL147154A (en) 2005-11-20
AU6721300A (en) 2001-04-30
CA2379572A1 (en) 2001-04-05
MXPA02003311A (es) 2002-10-04
IS6223A (is) 2002-01-08
OA12024A (en) 2006-04-19
US6369094B1 (en) 2002-04-09
NZ516093A (en) 2005-01-28
JP2003510318A (ja) 2003-03-18
ZA200202406B (en) 2003-05-28
ES2200911T3 (es) 2004-03-16
PE20010662A1 (es) 2001-06-23
GB9922963D0 (en) 1999-12-01
JP3795395B2 (ja) 2006-07-12
PA8498901A1 (es) 2004-02-07
AU779580B2 (en) 2005-01-27
BR0014272A (pt) 2002-05-21
TNSN00187A1 (fr) 2005-11-10
HUP0202821A2 (hu) 2003-01-28
CN1364166A (zh) 2002-08-14
WO2001023377A2 (en) 2001-04-05
DE60004262T2 (de) 2004-01-22
CA2379572C (en) 2006-11-14
WO2001023377A3 (en) 2002-03-07
CU23200A3 (es) 2007-04-06
EA200200302A1 (ru) 2002-10-31
WO2001023377A9 (en) 2002-03-28
GT200000159A (es) 2002-03-20
KR100479897B1 (ko) 2005-03-31
TWI265926B (en) 2006-11-11
TR200200804T2 (tr) 2002-07-22
UA72272C2 (uk) 2005-02-15
AR025779A1 (es) 2002-12-11
EP1233960B1 (en) 2003-07-30
PT1233960E (pt) 2003-11-28
PL354960A1 (en) 2004-03-22
NO20021525D0 (no) 2002-03-26
AP2004A (en) 2009-06-10

Similar Documents

Publication Publication Date Title
DK1360169T3 (da) Succinatsalt af O-desmethyl-venlafaxin
PT1210113E (pt) Composicoes de vacinas de combinacao
NO20033203D0 (no) Terapeutiske heterocykliske forbindelser
DK1233960T3 (da) Polymorft salt af anti-migræne lægemiddel
NO20020622L (no) Polymorfer av torsemid
PT1246817E (pt) Derivados de 4-fenil-1-piperazinilo, -piperidinilo e -tetra-hidropiridilo
DE60018619D1 (de) Befestigung rotierender Teile
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
PT1228056E (pt) Metodo de preparacao de citaloprame
DE60031450D1 (de) Polymorph v von torasemid
DK1246827T3 (da) Nye polymorfe former af olanzapin
EE200100381A (et) Morfolinobensamiidi uued soolad
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
PT1175417E (pt) Compostos substituidos de benzolactamas
ID30381A (id) Penggunaan arilalkanoilpiridazina
PT1232141E (pt) Eteres de o-desmetil-venlafaxina
PT1020132E (pt) Aba de puxar destacavel
DK1227795T3 (da) Lipidkompleks af alkycycliner
FI991322A0 (fi) Menetelmä yhteisvastuun siirtämiseksi
DE29904693U1 (de) Gehhilfe
FI990304A0 (fi) Hukkumisvaaran tunnistin
EE200200053A (et) Isoretinoiini valmistamise protsess
DK1085840T3 (da) Mikrokeratom til udövelse af hornhinderesektioner
DK1146035T3 (da) Krystalpolymorfi af aminoethylphenoxyeddikesyrederivat
IS5544A (is) Nýtt fosfatsalt af ísóprópýl-metýl-[2-(3-n-própoxýfenoxý)-etýl]amíni